$GH

3 theses

bullish 0%neutral 0%bearish 100%

Avg return (6m)

—

Win rate (6m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 18, 4:30 PM ET

$GHSEC Form 4bearish

Kalia Kumud · Chief Information Officer at Guardant Health, Inc. · 16d agono track record yet

Sold 4,000 @ $158.05 avg · $632,193 · 2026-09-11

Form 4: Kalia Kumud sold GH

Kalia Kumud (Chief Information Officer at Guardant Health, Inc.) reported an open-market sale of 4,000 shares of GH at an average $158.05, roughly $632,193, in a Form 4 filed 2026-09-14.

At post $167.84Now $179.38+6.9% since postedas of Sep 18, 4:30 PM ET

1d+4.7%

3d+9.1%

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$GHSEC Form 4bearish

Monroe Terilyn J. · Chief People Officer at Guardant Health, Inc. · 48d agono track record yet

Sold 46,300 @ $165.12 avg · $7,645,218 · 2026-08-12

Form 4: Monroe Terilyn J. sold GH

Monroe Terilyn J. (Chief People Officer at Guardant Health, Inc.) reported an open-market sale of 46,300 shares of GH at an average $165.12, roughly $7,645,218, in a Form 4 filed 2026-08-13.

At post $160.62Now $179.38+11.7% since postedas of Sep 18, 4:30 PM ET

1d-2.1%

3d-2.1%

1w+4.5%

1m-2.0%

3m—

6m—

1y—

View filing on SEC.gov →

$GHSEC Form 4bearish

Freeman Chris · Chief Commercial Officer at Guardant Health, Inc. · 50d agono track record yet

Sold 63,605 @ $169.58 avg · $10,786,111 · 2026-08-10

Form 4: Freeman Chris sold GH

Freeman Chris (Chief Commercial Officer at Guardant Health, Inc.) reported an open-market sale of 63,605 shares of GH at an average $169.58, roughly $10,786,111, in a Form 4 filed 2026-08-11.

At post $165.11Now $179.38+8.6% since postedas of Sep 18, 4:30 PM ET

1d—

3d-4.8%

1w-3.0%

1m-3.7%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.